FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308045201> ?p ?o ?g. }

• W4308045201 endingPage "e0277087" @default.
• W4308045201 startingPage "e0277087" @default.
• W4308045201 abstract "Background Only a few observational studies using small patient samples and one subgroup analysis have compared norepinephrine and dopamine for the treatment of cardiogenic shock (CS). The objective of the present study was to investigate whether the use of norepinephrine was associated with improvements in clinical outcomes in CS patients compared to dopamine. Methods We retrospectively reviewed hospital medical records of patients who were admitted to cardiac intensive care unit from 2012 to 2018. We included 520 patients with CS in this analysis. The primary outcome was in-hospital mortality, and serial hemodynamic data were also assessed. Results As a first-line vasopressor, dopamine was used in 156 patients (30%) and norepinephrine in 364 patients (70%). Overall, the norepinephrine group had significantly higher severity of shock, arrest at presentation, vital signs, and lactic acid than did the dopamine group at the time of vasopressor initiation. Nevertheless, in the norepinephrine group, additional vasopressor was required in 123 patients (33.8%), which was a significantly smaller percentage than the 92 patients (56.4%) in the dopamine group who required additional vasopressor (p < 0.001). There was no significant difference in in-hospital mortality between the two groups (26.9% and 31.9%, respectively, p = 0.26). In addition, the incidence of arrhythmia was not different between the two groups (atrial fibrillation, 12.2% vs. 15.7%, p = 0.30; ventricular tachyarrhythmia, 19.9% vs. 25.3%, p = 0.18). Conclusions The use of norepinephrine as a first-line vasopressor was not associated with reductions of in-hospital mortality or arrythmia but could reduce use of additional vasopressors in CS patients." @default.
• W4308045201 created "2022-11-07" @default.
• W4308045201 creator A5003620021 @default.
• W4308045201 creator A5010334767 @default.
• W4308045201 creator A5010864344 @default.
• W4308045201 creator A5012918239 @default.
• W4308045201 creator A5014017983 @default.
• W4308045201 creator A5017541279 @default.
• W4308045201 creator A5022049883 @default.
• W4308045201 creator A5023243707 @default.
• W4308045201 creator A5026332399 @default.
• W4308045201 creator A5048220648 @default.
• W4308045201 creator A5059693822 @default.
• W4308045201 creator A5068110122 @default.
• W4308045201 creator A5073009003 @default.
• W4308045201 creator A5086828665 @default.
• W4308045201 date "2022-11-03" @default.
• W4308045201 modified "2023-10-18" @default.
• W4308045201 title "Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock" @default.
• W4308045201 cites W1484146179 @default.
• W4308045201 cites W1583340290 @default.
• W4308045201 cites W1979579109 @default.
• W4308045201 cites W2002926363 @default.
• W4308045201 cites W2002961373 @default.
• W4308045201 cites W2023259170 @default.
• W4308045201 cites W2034185700 @default.
• W4308045201 cites W2095944485 @default.
• W4308045201 cites W2106703370 @default.
• W4308045201 cites W2129429230 @default.
• W4308045201 cites W2130232926 @default.
• W4308045201 cites W2147615829 @default.
• W4308045201 cites W2224057980 @default.
• W4308045201 cites W2275563318 @default.
• W4308045201 cites W2335872134 @default.
• W4308045201 cites W2565036671 @default.
• W4308045201 cites W2622236113 @default.
• W4308045201 cites W2736237262 @default.
• W4308045201 cites W2755584350 @default.
• W4308045201 cites W2792209290 @default.
• W4308045201 cites W2945771063 @default.
• W4308045201 cites W3027692247 @default.
• W4308045201 cites W3029617361 @default.
• W4308045201 cites W3094765347 @default.
• W4308045201 cites W3161949101 @default.
• W4308045201 doi "https://doi.org/10.1371/journal.pone.0277087" @default.
• W4308045201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36327286" @default.
• W4308045201 hasPublicationYear "2022" @default.
• W4308045201 type Work @default.
• W4308045201 citedByCount "0" @default.
• W4308045201 crossrefType "journal-article" @default.
• W4308045201 hasAuthorship W4308045201A5003620021 @default.
• W4308045201 hasAuthorship W4308045201A5010334767 @default.
• W4308045201 hasAuthorship W4308045201A5010864344 @default.
• W4308045201 hasAuthorship W4308045201A5012918239 @default.
• W4308045201 hasAuthorship W4308045201A5014017983 @default.
• W4308045201 hasAuthorship W4308045201A5017541279 @default.
• W4308045201 hasAuthorship W4308045201A5022049883 @default.
• W4308045201 hasAuthorship W4308045201A5023243707 @default.
• W4308045201 hasAuthorship W4308045201A5026332399 @default.
• W4308045201 hasAuthorship W4308045201A5048220648 @default.
• W4308045201 hasAuthorship W4308045201A5059693822 @default.
• W4308045201 hasAuthorship W4308045201A5068110122 @default.
• W4308045201 hasAuthorship W4308045201A5073009003 @default.
• W4308045201 hasAuthorship W4308045201A5086828665 @default.
• W4308045201 hasBestOaLocation W43080452011 @default.
• W4308045201 hasConcept C126322002 @default.
• W4308045201 hasConcept C164705383 @default.
• W4308045201 hasConcept C177713679 @default.
• W4308045201 hasConcept C2776376669 @default.
• W4308045201 hasConcept C2776850375 @default.
• W4308045201 hasConcept C2778514916 @default.
• W4308045201 hasConcept C2781005686 @default.
• W4308045201 hasConcept C2781300812 @default.
• W4308045201 hasConcept C2987404301 @default.
• W4308045201 hasConcept C42219234 @default.
• W4308045201 hasConcept C500558357 @default.
• W4308045201 hasConcept C513476851 @default.
• W4308045201 hasConcept C71924100 @default.
• W4308045201 hasConceptScore W4308045201C126322002 @default.
• W4308045201 hasConceptScore W4308045201C164705383 @default.
• W4308045201 hasConceptScore W4308045201C177713679 @default.
• W4308045201 hasConceptScore W4308045201C2776376669 @default.
• W4308045201 hasConceptScore W4308045201C2776850375 @default.
• W4308045201 hasConceptScore W4308045201C2778514916 @default.
• W4308045201 hasConceptScore W4308045201C2781005686 @default.
• W4308045201 hasConceptScore W4308045201C2781300812 @default.
• W4308045201 hasConceptScore W4308045201C2987404301 @default.
• W4308045201 hasConceptScore W4308045201C42219234 @default.
• W4308045201 hasConceptScore W4308045201C500558357 @default.
• W4308045201 hasConceptScore W4308045201C513476851 @default.
• W4308045201 hasConceptScore W4308045201C71924100 @default.
• W4308045201 hasIssue "11" @default.
• W4308045201 hasLocation W43080452011 @default.
• W4308045201 hasLocation W43080452012 @default.
• W4308045201 hasLocation W43080452013 @default.
• W4308045201 hasLocation W43080452014 @default.
• W4308045201 hasOpenAccess W4308045201 @default.
• W4308045201 hasPrimaryLocation W43080452011 @default.

• next